Health Canada approves first treatment for Duchenne muscular dystrophy
Neuroblastoma treatment receives Orphan Drug Designation
Base to Base biotech podcast 30: Life sciences in Lithuania
Encouraging results from Canavan disease trial
ReCatalyst closes oversubscribed seed financing round